Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-15

Clinical Trial Update: Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing how moderate-intensity physical activity affects PK-guided extended half-life factor VIII concentrates for prophylaxis in severe hemophi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chulalongkorn University | Conditions: Hemophilia | Phase 4 | Status: COMPLETED